04:37 PM EDT, 09/24/2025 (MT Newswires) -- uniQure (QURE) said late Wednesday it has begun a $200 million underwritten public offering of ordinary shares and pre-funded warrants.

The gene therapy company said all securities will be offered by the company, with underwriters granted a 30-day option to buy up to 15% more shares or warrants.

Leerink Partners, Stifel, Van Lanschot Kempen, and Guggenheim Securities are acting as joint bookrunners.

The stock closed up 248% on Wednesday, with 69.2 million shares traded compared with its average volume of 1.1 million.